EUVIMEDEUVIMED entdecken
Crossref

Functional Validation and Phenotypic Spectrum of Splice‐Site Variants in CHD7 , FGFR1 , and ANOS1 in Congenital Hypogonadotropic Hypogonadism

Yuting Li iD, Pingchuan Zhang, Jun Guan, Chengli He, Jianglan Fu, Ruizhi Zheng, Danna Chen, Xiong Tang, Meichao Men, Zhiheng Chen, Jia-Da Li

Clinical Genetics · 2026

DOI: 10.1111/cge.70114 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Genetics, 2026. Verfasst von Yuting Li und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, the Third Xiangya Hospital, Central South University, Changsha, China. Hauptthemen laut MEDLINE: Receptor, Fibroblast Growth Factor, Type 1, Hypogonadism, RNA Splice Sites, Nerve Tissue Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: National Natural Science Foundation of China, the Natural Science Foundation of Hunan Province, Foundation of Education Bureau of Hunan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

To determine the prevalence of CHD7 , FGFR1 and ANOS1 variants and the impacts of their splicing variants on mis‐splicing in patients with congenital hypogonadotropic hypogonadism (CHH). Based on the whole‐exome sequencing data from 280 CHH probands, we identified 15 potential splice‐site variants in CHD7 , ANOS1 and FGFR1 by using in silico software. The functional consequences of these variants were analyzed by the minigene assay or RT‐PCR analyses of RNA taken from the peripheral lymphocytes. Detailed phenotyping was performed in the CHH patients harboring deleterious variants and their available family members. 11 out of 15 potential splice‐site variants were demonstrated to cause mis‐splicing, resulting in loss of function through deletion, insertion or frameshift of amino acids in the proteins. Most patients with deleterious splice‐site variants in CHD7 , ANOS1 , FGFR1 presented with gene‐specific non‐reproductive phenotypes, confirming the pathogenic contribution of these variants to CHH. Our study indicated that splice‐site variants in CHD7 , ANOS1 , FGFR1 underlie the genetic basis of ~3.9% of CHH patients, warranting the inclusion of potential splice‐site variants for genetic diagnosis and counseling of CHH.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptor, Fibroblast Growth Factor, Type 1HypogonadismRNA Splice SitesNerve Tissue ProteinsDNA-Binding ProteinsDNA HelicasesHumansPhenotypeMaleFemaleExome SequencingPedigreeMutationRNA SplicingGenetic Predisposition to DiseaseAdolescentAdultExtracellular Matrix Proteins

Stichwörter der Autor:innen

CHHKallmann syndromeMinigenesplice‐site variants

Substanzen

Receptor, Fibroblast Growth Factor, Type 1FGFR1 protein, humanCHD7 protein, humanANOS1 protein, humanRNA Splice SitesNerve Tissue ProteinsDNA-Binding ProteinsDNA HelicasesExtracellular Matrix Proteins

Autor:innen und Institutionen

  • Department of Pediatrics, the Third Xiangya Hospital, Central South University, Changsha, China.
  • Center for Medical Genetics, School of Life Sciences, Central South University, Changsha, China.
  • Hunan Key Laboratory of Medical Genetics, Central South University, Changsha, China.
  • Hunan Key Laboratory of Animal Models for Human Diseases, Central South University, Changsha, China.
  • MOE Key Laboratory of Rare Pediatric Diseases, Central South University, Changsha, China.
  • Department of Endocrinology, The People's Hospital of Henan Province, Zhengzhou, China.

ORCID-Profile: Yuting Li

Förderung

  • National Natural Science Foundation of China
  • the Natural Science Foundation of Hunan Province
  • Foundation of Education Bureau of Hunan Province
  • the Hunan Key Project
  • the Graduate Innovation Project of Central South University
  • Natural Science Foundation of Hunan Province

Zitieren

APA

Li, Y., Zhang, P., Guan, J., He, C., Fu, J., Zheng, R., Chen, D., Tang, X., Men, M., Chen, Z., & Li, J. D. (2026). Functional Validation and Phenotypic Spectrum of Splice‐Site Variants in CHD7 , FGFR1 , and ANOS1 in Congenital Hypogonadotropic Hypogonadism. Clinical Genetics. https://doi.org/10.1111/cge.70114

Vancouver

Li Y, Zhang P, Guan J, He C, Fu J, Zheng R, et al. Functional Validation and Phenotypic Spectrum of Splice‐Site Variants in CHD7 , FGFR1 , and ANOS1 in Congenital Hypogonadotropic Hypogonadism. Clinical Genetics. 2026. doi:10.1111/cge.70114

BibTeX
@article{Li2026,
  author = {Li, Yuting and Zhang, Pingchuan and Guan, Jun and He, Chengli and Fu, Jianglan and Zheng, Ruizhi and Chen, Danna and Tang, Xiong and Men, Meichao and Chen, Zhiheng and Li, Jia-Da},
  title = {Functional Validation and Phenotypic Spectrum of Splice‐Site Variants in CHD7 , FGFR1 , and ANOS1 in Congenital Hypogonadotropic Hypogonadism},
  journal = {Clinical Genetics},
  year = {2026},
  doi = {10.1111/cge.70114}
}
Kostenlos starten →